SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME -- Ignore unavailable to you. Want to Upgrade?

To: dr.praveen who wrote (56)8/31/2006 2:34:59 PM
From: keokalani'nui  Read Replies (2) | Respond to of 285
 
I don't look for much increased efficacy over low dose, but should be some. When it's all done--and rest of low dose data is in--I think the joy will come from highly SS efficacy in both doses and low peevalue will be all that's needed for speculation of co. sale or huge partnership.

But I sold some because drug business is muy treacherous. Still, an important position for me.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News